Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02109822 · ClinicalTrials.gov registry record
Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 220
- Enrollment target
NCT02109822: Completed study, sponsored by University of Washington.
NCT02109822 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02109822 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 220 participants
- Enrollment target
Study Summary
The goal of this research study is to better understand current treatment practices for pulmonary exacerbations (lung infections) and whether the Cystic Fibrosis National Patient Registry (CFFNPR)can be used for this type of study.
Primary Outcome
Assess feasibility using the CFF National Patient Registry as measured by the accuracy of data entry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-06 |
What the finished NCT02109822 record still lists
NCT02109822 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02109822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02109822 about?
NCT02109822 is a clinical study titled "Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CF". The goal of this research study is to better understand current treatment practices for pulmonary exacerbations (lung infections) and whether the Cystic Fibrosis National Patient Registry (CFFNPR)can be used for this type of study.
What is the current status of trial NCT02109822?
This trial is currently completed. The enrollment target is 220 participants. The study started on 2014-01. Estimated completion is 2015-06.
Who is sponsoring clinical trial NCT02109822?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia